{"schema_version":"secwatch.filing_event.v1","accession":"0000929638-23-001741","form_type":"8-K","ticker":"ICU","cik":"0001831868","company_name":"SeaStar Medical Holding Corp","filed_at":"2023-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.985355+00:00","generated_at":"2026-06-13T23:11:14.555919+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"SeaStar Medical receives Nasdaq deficiency notice for MVLS below $35M minimum","bullets":["Nasdaq letter dated June 14, 2023: MVLS below $35M for 35 consecutive business days.","Company has 180 days (until Dec 11, 2023) to regain compliance by closing at $35M+ for 10 consecutive days.","No immediate delisting; stock continues trading on Nasdaq Capital Market.","Company considering options including extension request or appeal to Nasdaq Hearings Panel."],"urls":{"canonical":"https://secwatch.observer/filing/0000929638-23-001741","json":"https://secwatch.observer/filing/0000929638-23-001741.json","markdown":"https://secwatch.observer/filing/0000929638-23-001741.md","text":"https://secwatch.observer/filing/0000929638-23-001741.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831868/000092963823001741/0000929638-23-001741-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831868/000092963823001741/a8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T23:11:14.555919+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a7a63065f7f417b48f9e6eb477a24069292e39e7","claim":"SeaStar Medical Holding Corp received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).","evidence_excerpt":"June 14, 2023, SeaStar Medical Holding Corporation (the “Company”) received a letter (the “Nasdaq Staff Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty-five (35) consecutive business days, the Market Value of Listed Securities (“MVLS”) for the Company’s common stock, par value $0.0001 per share, had been below the $35 million minimum requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has been provided an initial period of 180","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831868/000092963823001741/0000929638-23-001741-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5550(b)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}